71 results
Page 3 of 4
DEFA14A
um6ow9qffjogktzl
24 Apr 20
Additional proxy soliciting materials
12:00am
8-K
EX-1.1
bd4o5yfmrl4d547c5
7 Oct 19
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
9:29pm
8-K
EX-1.2
ajjoblqd5xmc
7 Oct 19
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
9:29pm
8-K
EX-99.1
2pi947q
9 Sep 19
Other Events
12:00am
8-K
EX-99.1
a9g xga2pumyeue15
27 Jun 19
Regulation FD Disclosure
12:04pm
8-K
EX-99.1
8dha8mj 3181a2mgt
27 Jun 19
Other Events
8:05am
DEFA14A
zpqu0f5uzqklab hv
24 Apr 19
Additional proxy soliciting materials
5:30pm
8-K
EX-99.1
h5ad21r56ft
11 Mar 19
Regulation FD Disclosure
2:51pm
424B5
klippa4yb0f3rvz
21 Feb 19
Prospectus supplement for primary offering
9:24pm
424B5
jg1ubqvuuv
21 Feb 19
Prospectus supplement for primary offering
9:22pm
8-K
EX-1.2
4q6p0gbu4vw
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
8-K
EX-1.1
azohr2r
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
424B5
gnrls9lnmm6b
19 Feb 19
Prospectus supplement for primary offering
4:06pm